| bioMérieux S.A.. (4/24/19). "Press Release: bioMérieux – First-Quarter 2019 Business Review". Marcy l’Étoile. |
2019-04-24 |
| Novartis AG. (4/24/19). "Press Release: Novartis Starts 2019 with Strong Sales and Double Digit Core Operating Income Growth, Mayzent Launch and Alcon Spin-off, Profit Guidance Upgraded". Basel. |
2019-04-24 |
| ADC Therapeutics S.A.. (4/24/19). "Press Release: ADC Therapeutics and Adagene Announce License Agreement". Lausanne & Suzhou. |
2019-04-24 |
| InfanDx AG. (4/24/19). "Press Release: InfanDx AG Closes 5.3 Mio EUR Financing". Cologne & Bonn. |
2019-04-24 |
| Merck KGaA. (4/24/19). "Press Release: Merck Introduces New Greener Solvent, Cyrene". Darmstadt. |
2019-04-24 |
| BioCity Group Ltd.. (4/24/19). "Press Release: BioCity Invests in Carbon Recycling Start-up, Deep Branch Biotechnology". |
2019-04-24 |
| Velabs Therapeutics GmbH. (4/24/19). "Press Release: Velabs Therapeutics to Cooperate with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening". Heidelberg. |
2019-04-24 |
| Juvenescence Ltd.. (4/24/19). "Press Release: Juvenescence Announces Appointment of David Ellam as Chief Financial Officer". Tortola, British Virgin Islands. |
2019-04-24 |
| ERS Genomics Ltd.. (4/23/19). "Press Release: US Patent Office Grants Charpentier/Doudna Key CRISPR Patent". Dublin. |
2019-04-23 |
| Biocartis Group N.V.. (4/23/19). "Press Release: Biocartis Announces Global Collaboration with Covance". Mechelen. |
2019-04-23 |
| Roche. (4/23/19). "Press Release: Roche Launches New Ventana HER2 Dual ISH Companion Diagnostic Test for Breast and Gastric Cancer Patients Eligible for Targeted Therapy". Basel. |
2019-04-23 |
| MorphoSys AG. (4/23/19). "Press Release: MorphoSys and Galapagos Announce Initiation of GECKO Phase 2 Study with MOR106 in Atopic Dermatitis Patients". Planegg & Mechelen. |
2019-04-23 |
| Cobo Technologies ApS. (4/23/19). "News: Welcome to Our New COO, Hasse Herlevsen". |
2019-04-23 |
| Start Codon Ltd.. (4/23/19). "Press Release: Start Codon Founded in Cambridge, UK, to Deliver Premier Life Science and Healthcare Business Acceleration Program". Cambridge. |
2019-04-23 |
| Fulcrum Therapeutics, Inc.. (4/23/19). "Press Release: Fulcrum Therapeutics Acquires Global Rights to Losmapimod, a Potential Disease-Modifying Therapy for Facioscapulohumeral Muscular Dystrophy". Cambridge, MA. |
2019-04-23 |
| Panaceutics Nutrition LLC. (4/22/19). "Press Release: DSM and Panaceutics Announce Partnership to Bring Cost-Effective Personalized Nutrition to Consumers". Parsippany, NJ. |
2019-04-22 |
| Bio-Rad Laboratories, Inc.. (4/22/19). "Press Release: Bio-Rad Appoints Andrew Last as Executive Vice President and Chief Operating Officer". Hercules, CA. |
2019-04-22 |
| Poseida Therapeutics, Inc.. (4/22/19). "Press Release: Poseida Therapeutics Raises $142 Million in Series C Financing". San Diego, CA. |
2019-04-22 |
| HalioDx SAS. (4/19/19). "Press Release: HalioDx Signs an Exclusive Agreement with Genecast to Make Immunoscore Available in China". Marseille. |
2019-04-19 |
| CRS Clinical Research Services Andernach GmbH. (4/19/19). "Press Release: CRS Receives CRO Leadership Awards. Recognised for Excellence in Early Clinical Development". Andernach. |
2019-04-19 |
| CRS Clinical Research Services Andernach GmbH. (4/19/19). "Press Release: Management Buy-Out at CRS. Apleonex AG Buys LTS AG’s Shares in CRS Clinical Research Services Andernach GmbH". Andernach. |
2019-04-19 |
| Arrakis Therapeutics, Inc.. (4/18/19). "Press Release: Arrakis Therapeutics Announces $75 Million Series B Financing To Advance a New Class of Small-Molecule Medicines Targeting RNA". Waltham, MA. |
2019-04-18 |
| Evotec SE. (4/18/19). "Press Release: Evotec Completes Repayment of EUR 140 m Acquisition Loan". Hamburg. |
2019-04-18 |
| Genfit S.A.. (4/18/19). "Press Release: Genfit Announces FDA Grant of Breakthrough Therapy Designation to Elafibranor for the Treatment of PBC". Lille & Boston, MA. |
2019-04-18 |
| Silence Therapeutics plc. (4/18/19). "Press Release: Silence Therapeutics Appoints Dr. Rob Quinn as Chief Financial Officer". London. |
2019-04-18 |
| [iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. |
2019-04-17 |
| Cerenis Therapeutics S.A.. (4/17/19). "Press Release: Cerenis Therapeutics Has Decided to Terminate the Proposed Merger with H4Orphan Pharma". Toulouse. |
2019-04-17 |
| Kiadis Pharma N.V.. (4/17/19). "Press Release: Kiadis to Acquire CytoSen Therapeutics, Inc.". Amsterdam. |
2019-04-17 |
| PureTech Health plc. (4/17/19). "Press Release: PureTech Health Announces Collaboration with Boehringer Ingelheim to Advance Immuno-oncology Product Candidates Using Its Lymphatic Targeting Platform". Boston, MA. |
2019-04-17 |
| Hookipa Pharma Inc.. (4/17/19). "Press Release: Hookipa Pharma Announces Pricing of Initial Public Offering". New York, NY & Vienna. |
2019-04-17 |
| Centogene AG. (4/17/19). "Press Release: Centogene Appoints AI Industry Leader Dr. Carsten Ullrich as Director of Artificial Intelligence". Rostock & Berlin. |
2019-04-17 |
| Aidoc. (4/17/19). "Press Release: We Raised 27 Million to Continue Our Mission in Making AI Standard of Care in Radiology". |
2019-04-17 |
| Roche. (4/17/19). "Press Release: Roche Reports a Strong Start in 2019 and Raises the Outlook for the Full-year". Basel. |
2019-04-17 |
| Affimed N.V.. (4/17/19). "Press Release: Affimed Provides Regulatory Update on AFM11 Clinical Program". Heidelberg. |
2019-04-17 |
| Inivata Ltd.. (4/16/19). "Press Release: Inivata, Thermo Fisher Scientific, and Genomics England Successfully Complete First Phase of Study Assessing Plasma Samples and Potential of Liquid Biopsy". |
2019-04-16 |
| Lipotype GmbH. (4/16/19). "Press Release: Worldwide First and Only Shotgun Lipidomics Service Provider with Official GMP Certificate". Dresden. |
2019-04-16 |
| Cevec Pharmaceuticals GmbH. (4/16/19). "Press Release: Cevec Closes Major Financing Round to Further Expand and Commercialize Its Viral Vector Manufacturing Platform". Cologne. |
2019-04-16 |
| Biotechpharma UAB. (4/16/19). "Press Release: Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000L". Vilnius. |
2019-04-16 |
| Bruker Corporation. (4/16/19). "Press Release: Bruker and the Translational Metabolic Laboratory at Radboud University Medical Center Announce the Establishment of a Joint Center of Excellence for Translational Omics". Nijmegen. |
2019-04-16 |
| Kintai Therapeutics, Inc.. (4/16/19). "Press Release: Flagship Pioneering Unveils Kintai Therapeutics and Appoints Pharmaceutical Drug Developer Paul-Peter Tak, M.D., Ph.D. as Chief Executive Officer". Cambridge, MA. |
2019-04-16 |
| Atomwise, Inc.. (4/16/19). "Press Release: DNDi and Atomwise Collaborate to Advance Drug Development Using AI for Neglected Diseases". Geneva & San Francisco, CA. |
2019-04-16 |
| MLM Medical Labs GmbH. (4/15/19). "Press Release: Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project to Enable Development and Implementation of Novel Safety Biomarkers". Mönchengladbach. |
2019-04-15 |
| Catalent, Inc.. (4/15/19). "Press Release: Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion". Somerset, NJ & Baltimore, MD. |
2019-04-15 |
| bioMérieux S.A.. (4/15/19). "Press Release: “Global-PPS”, a Survey of Antibiotic Use and Bacterial Resistance in Hospitals Worldwide, Tops the 200,000 Patients". Marcy l’Étoile & Antwerp. |
2019-04-15 |
| Agilent Technologies Inc.. (4/15/19). "Press Release: Agilent Introduces New Mass Spectrometry Solutions". Santa Clara, CA. |
2019-04-15 |
| Cobo Technologies ApS. (4/15/19). "News: Cobo Technologies Member of NIST Genome Editing Consortium, US". |
2019-04-15 |
| bioMérieux S.A.. (4/1/19). "Press Release: University of Antwerp, bioMérieux, and Wellcome Trust to Coordinate VALUE-Dx, a European Public-Private Partnership to Fight Antimicrobial Resistance through Diagnostics". Antwerp, London & Marcy l’Eoile. |
2019-04-14 |
| Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsværd. |
2019-04-12 |
| Immunic, Inc.. (4/12/19). "Press Release: Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases". San Diego, CA & Martinsried. |
2019-04-12 |
| Curetis N.V.. (4/12/19). "Press Release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019". Vienna, Holzgerlingen & Amsterdam. |
2019-04-12 |
| Sophia Genetics S.A.. (4/11/19). "Press Release: Sophia Genetics Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection". Lausanne. |
2019-04-11 |
| Evotec SE. (4/11/19). "Press Release: Evotec and Indivumed Announce Strategic Drug Discovery Collaboration on Precision Medicine for Colorectal Cancer". Hamburg. |
2019-04-11 |
| BioStrata Ltd.. (4/11/19). "Press Release: BioStrata Launches Targeted News Distribution Service for Life Science and Healthcare Companies". Cambridge. |
2019-04-11 |
| Curetis N.V.. (4/11/19). "Press Release: Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019". Amsterdam & Holzgerlingen. |
2019-04-11 |
| Athira Pharma, Inc.. (4/11/19). "Press Release: M3 Biotechnology Announces Name Change to Athira Pharma, Inc.". |
2019-04-11 |
| Centogene AG. (4/10/19). "Press Release: Centogene Launches CentoMetabolic Panel for Integrated Multiomic Testing for Metabolic Diseases". Rostock & Berlin. |
2019-04-10 |
| Synaffix B.V.. (4/10/19). "Press Release: Synaffix Announces $125m License Agreement with Shanghai Miracogen". Amsterdam. |
2019-04-10 |
| Protagen Protein Services GmbH. (4/10/19). "Press Release: Protagen Protein Services and BioAnalytix Merge to Create Global Analytic Service Partner for Biopharmaceuticals". Heilbronn & Boston, MA. |
2019-04-10 |
| Probiodrug AG. (4/9/19). "Press Release: Probiodrug Raises EUR 8.2 Million from Investors in Successful Private Placement of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). |
2019-04-09 |
| Theranexus S.A.. (4/9/19). "Press Release: Theranexus Announces Research Collaboration with IRISA Using Artificial Intelligence Technologies to Enhance Therapeutic Targeting of Neurological Interactions". Lyon. |
2019-04-09 |
| Bruker Corporation. (4/9/19). "Press Release: DKSH and Bruker AXS Strengthen Partnership in China". Shanghai. |
2019-04-09 |
| UCB S.A.. (4/9/19). "Press Release: FDA Approves Evenity (Romosozumab) for the Treatment Of Osteoporosis in Postmenopausal Women at High Risk for Fracture". Brussels. |
2019-04-09 |
| Igem Therapeutics Ltd.. (4/9/19). "Press Release: Igem Therapeutics Appoints Dr David Chiswell as a Non-Executive Chairman". London. |
2019-04-09 |
| Polyphor Ltd.. (4/9/19). "Press Release: Polyphor Appoints Gökhan Batur as Chief Commercial Officer". Allschwil. |
2019-04-09 |
| Avectas Ltd.. (4/9/19). "Press Release: Avectas Raises $10 Million in Equity Finance". Ireland. |
2019-04-09 |
| Kymab Ltd.. (4/8/19). "Press Release: Kymab Appoints Simon Sturge as Chief Executive Officer". Cambridge. |
2019-04-08 |
| Metrion Biosciences Ltd.. (4/8/19). "Press Release: Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer". Cambridge. |
2019-04-08 |
| Uniqure N.V.. (4/8/19). "Press Release: Uniqure Receives FDA Fast Track Designation for AMT-130 Gene Therapy for the Treatment of Huntington’s Disease". Lexington, MA & Amsterdam. |
2019-04-08 |
| Phenex Pharmaceuticals AG. (4/5/19). "Press Release: Phenex Collaborates with Mathias Heikenwälder’s Research Group from DKFZ (German Cancer Research Center)". Ludwigshafen. |
2019-04-05 |
| Eppendorf AG. (4/5/19). "Press Release: Eppendorf AG Increases Sales and Earnings in 2018 and Accelerates Organic Growth". Hamburg. |
2019-04-05 |
| Calliditas Therapeutics AB. (4/5/19). "Press Release: Elmar Schnee and Diane Parks Proposed as New Board Members of Calliditas Therapeutics". Stockholm. |
2019-04-05 |
| Novartis AG. (4/4/19). "Press Release: Novartis Updates on the Migraine Collaboration with Amgen". Basel. |
2019-04-04 |
| Nanobiotix S.A.. (4/4/19). "Press Release: Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval". Paris & Cambridge, MA. |
2019-04-04 |
| Medigene AG. (4/4/19). "Press Release: Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia". Martinsried & Hong Kong. |
2019-04-04 |
| Probiodrug AG. (4/4/19). "Press Release: Probiodrug AG Has Mandated Oddo Seydler Bank AG as Designated Sponsor. The Shares Are Trading on XETRA, the Electronic Trading Platform of Deutsche Börse". Halle (Saale). |
2019-04-04 |
| Crescendo Biologics Ltd.. (4/4/19). "Press Release: Theodora Harold to Be Appointed New CEO at Crescendo Biologics". Cambridge. |
2019-04-04 |
| Gesynta Pharma AB. (4/4/19). "Press Release: Gesynta Pharma Secures 6 MEUR for Development Programs in Financing Round Led by Industrifonden". Solna. |
2019-04-04 |
| Curetis N.V.. (4/4/19). "Press Release: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform". Amsterdam, San Diego, CA & Holzgerlingen. |
2019-04-04 |
| Inscripta, Inc.. (4/4/19). "Press Release: Inscripta Completes $20m Expansion of Series C Financing, Increasing Total Round to $105.5mm". Boulder, CO. |
2019-04-04 |
| Dyne Therapeutics Inc.. (4/3/19). "Press Release: Dyne Therapeutics Launches with $50 Million Series A to Develop Targeted Therapies for Muscle Diseases". Cambridge, MA. |
2019-04-03 |
| Novartis AG. (4/3/19). "Press Release: Sandoz Resubmits Biosimilar Pegfilgrastim Application to US FDA". Holzkirchen. |
2019-04-03 |
| Roche. (4/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Withdrawal and Refiling of Premerger Notification and Report Form under the HSR Act and Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. |
2019-04-03 |
| Qiagen N.V.. (4/3/19). "Press Release: Qiagen and LabCorp Launch Collaboration to Provide Day-One Access for Patients to Innovative Companion Diagnostics at the Time of Drug Approvals". Hilden & Germantown, MD. |
2019-04-03 |
| Agomab Therapeutics N.V.. (4/3/19). "Press Release: AgomAb Therapeutics Completes Euros 21m Series A Financing". Ghent. |
2019-04-03 |
| Bruker Corporation. (4/3/19). "Press Release: Bruker Announces Acquisition of Rave LLC". Billerica, MA. |
2019-04-03 |
| ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. |
2019-04-03 |
| Editas Medicine, Inc.. (4/3/19). "Press Release: Editas Medicine and BlueRock Therapeutics Enter Strategic Research Collaboration and Cross-Licensing Agreement to Combine Genome Editing and Cell Therapy Platforms". Cambridge, MA. |
2019-04-03 |
| Exscientia Ltd.. (4/3/19). "Press Release: Exscientia Achieves Molecule Discovery Milestone as Part of GSK Collaboration". Oxford. |
2019-04-03 |
| Novartis AG. (4/2/19). "Press Release: Novartis First-in-class Cosentyx Approved in China for Psoriasis Patients". Basel. |
2019-04-02 |
| Nanobiotix S.A.. (4/2/19). "Press Release: Combination of First-in-Class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in Vivo Models of Lung Cancer". Paris & Cambridge, MA. |
2019-04-02 |
| Bayer AG. (4/2/19). "Press Release: Leaps by Bayer and Khloris Join Forces to Develop Induced Pluripotent Stem Cells (iPSCs) as Breakthrough Anti-cancer Vaccines". Leverkusen & South San Francisco, CA. |
2019-04-02 |
| Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Announces Agreement Securing Access To Large-scale, Commercial-grade Manufacturing Capacity at Brammer Bio". Brisbane, CA. |
2019-04-02 |
| Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy". Brisbane, CA & New York, NY. |
2019-04-02 |
| Sangamo Therapeutics, Inc.. (4/2/19). "Press Release: Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data". Brisbane, CA. |
2019-04-02 |
| Centogene AG. (4/2/19). "Press Release: Centogene Announces the Appointment of Dr. Flemming Ornskov to the Supervisory Board as Non-Executive Chairman". Rostock & Berlin. |
2019-04-02 |
| Lonza Group AG. (4/2/19). "Press Release: Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome". Copenhagen & Basel. |
2019-04-02 |
| Immunic AG. (4/2/19). "Press Release: Immunic Therapeutics to Present at the Needham Healthcare Conference on April 10". Planegg-Martinsried. |
2019-04-02 |
| Curetis N.V.. (4/2/19). "Press Release: Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance". Amsterdam & Holzgerlingen. |
2019-04-02 |
| Bio-Rad Laboratories, Inc.. (4/2/19). "Press Release: Bio-Rad Names Ilan Daskal Executive Vice President and Chief Financial Officer". Hercules, CA. |
2019-04-02 |
| PredictImmune Ltd.. (4/2/19). "Press Release: PredictImmune’s First Prognostic Test for IBD PredictSURE IBD, Launches in the UK and Ireland". Cambridge. |
2019-04-02 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 ... 64 65 66 ... 68 69 70 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
